Smartphone Solution Redefines Client Care
01/06/2010
Technology North Corp. is one step closer to bringing its TN ActiveCare iPhone applications to assisted living organizations thanks to $200,000 in product development support from NRC-IRAP and the Alberta Innovates Technology Futures Voucher program to further prototype development.
TEC VenturePrize winners for 2010
15/04/2010
Alberta’s best emerging entrepreneurs came with one mission, to be TEC Edmonton’s VenturePrize winners. The battle was won by Biolithic for the Fast Growth award and Alberta Carbon for the Student Business Plan award.
TEC VenturePrize semi-finalists for 2010
17/03/2010
Find out who the top business contestants for this years TEC VenturePrize competition.
New Lost-and-Found System for Edmonton Transit
04/02/2010
Lost your iPod on the bus? An Edmonton company called Hybrid Forge has been chosen to improve the way the city gets it back to you, through a pilot project that supports local technology companies.
Oil on ice: an industry 'game changer'
12/01/2010
The enormous power of ice, which through its freeze-thaw cycles can destroy roads, bridges and buildings, may soon also help boost oil and gas production.
TEC Edmonton: Manipulating the business gene
11/12/2009
Phil Halloran knows first-hand that there’s no easy way to get technology from the lab to market. Luckily, he hasn’t faced that challenge alone.
TEC Edmonton strengthens leadership team
8/12/2009
TEC Edmonton’s ability to provide technology transfer and business services to the region was significantly enhanced today with the appointment of Chris Lumb as TEC Edmonton’s CEO, and Dr. Randall Yatscoff as Vice President of the TEC Executive-in-Residence Program.
Window opens to Alberta's Innovation Voucher Pilot Program
08/10/2009
Companies have another opportunity to apply to the Alberta Innovation Voucher Pilot Program. These vouchers will help Alberta entrepreneurs develop their technology-based ideas into marketable products or services.
TheraCarb Appoints New CEO
01/10/2009
TheraCarb Inc. has appointed Dr. Mark Redmond as Chief Executive Officer. The announcement was made at the Banff Venture Forum (BVF) where the company met with members of the venture capital and financial markets and followed-up on its success as the BVF 2008 award-winning Life Sciences Technology company.
New company with wireless monitoring technology for health care
17/09/2009
Soon people with diabetes may have a wireless monitoring system that connects them with a clinician through Bluetooth technology. University of Alberta Faculty of Rehabilitation Medicine professor Masako Miyazaki, PhD, is the principle investigator who helped launch the spin-off company, Kanata Health Solutions Inc., which developed the Wireless Wearable Physiological Monitor (WWPM) as part of the new monitoring solution.
City TV - Breakfast Television interview
Let the Planning Begin! TEC VenturePrize Seminar Launch
15/09/2009
A business plan supplies you with a blueprint for success - it provides direction. Led by the University of Alberta’s School the TEC VenturePrize Seminar Series helps entrepreneurs transform their smart ideas into smart companies.
A new film star?
04/09/2009
At the recent University of Alberta Poultry Research Centre (PRC) annual meeting, researcher Dr. Mirko Betti previewed a new, barely visible product for the audience that is thinner than paper, opaque, flexible – and entirely edible.
IMBiotechnologies purchases 'Tumor Starvation Technology'
13/08/2009
IMBiotechnologies Ltd ("IMBio") announced today that the Company has completed purchase of all assets related to the Occlusin(R) tumor starvation technology from Paladin Labs Inc ("Paladin").
Strata Signs Agreement with University of Alberta for Bitumen Recovery Technology
9/07/2009
Strata Oil & Gas Inc. ("Strata") (OTCBB:SOIGF) has entered into an option agreement with the University of Alberta for the exclusive Canadian license to the technology relating to "Steam-Over-Solvent Injection for Heavy-Oil Recovery in Fractured Reservoirs" described in part in the Canadian patent application "Hydrocarbon Recovery Process for Fractured Reservoirs" (serial no. 2,639,997).
Agragen to Increase Oil Content in Camelina
11/06/2009
Agragen, a leader in using biotechnology to modify Camelina sativa to increase agronomically desirable traits, announces the acquisition of intellectual property rights that will increase oil content in the second generation oilseed crop.
Groundbreaking team can't stand still
06/05/2009
It's a bull market for Stephen Moore's University of Alberta animal genetics team, who were a key part of groundbreaking research that decoded the genetic secrets of cattle
Beef Genomics Discovery, Good News for Breeders
01/05/2009
A recent breakthrough in beef genomics research at the University of Alberta will help cattle producers select more efficient animals.
…and the 2009 TEC VenturePrize Grand Prize Winners are…
30/04/2009
Ambitious entrepreneurs from across Alberta let their presence be known at the 2009 TEC VenturePrize Awards Luncheon.
TEC VenturePrize announces Alberta’s cutting edge finalists
26/03/2009
For several years TEC VenturePrize has enticed Alberta’s entrepreneurs with incentives to grow businesses.
Woman Technopreneurs Showcase Their Ingenuity
18/03/2009
Edmonton, Alberta. Challenged to provide scientific solutions with market potential, the winners of the WISEST Innovation Contest, were announced at the Regional Alliance event.
Connecting Business Incubators with Entrepreneurs
18/03/2009
The Regional Alliance officially celebrated its 1st Milestone with the signing of a Memorandum of Understanding amongst five local business incubators.
Silver technology worth its ‘wait’ for Edmonton start-up
25/02/2009
TEC Edmonton’s portfolio company, Exciton Technologies Inc., has received a $500,000 grant from the Alberta Heritage Foundation for Medical Research.
BioMS recognized at Scrip Awards 2008
12/12/2008
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the Company was the recipient of the “Licensing Deal of the Year Award” at the 4th Annual Scrip Awards held in London, U.K.
TheraCarb recieves grant
29/10/2008
TheraCarb Inc. announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project titled “Testing of a therapeutic PolyBAIT concept for in vivo protection against Cholera Toxin.”
TheraCarb wins in class at Banff Venture Forum
20/10/2008
TheraCarb is pleased to announce that it was awarded best in class at the Banff Venture Forum (BVF), held on October 2nd and 3rd in Banff, Alberta, Canada.
TEC VenturePrize Business Plan Competition kicks off seventh year
20/10/2008
As Edmonton emerges as a centre for technology development, TEC Edmonton is leading commercialization efforts with programs like TEC VenturePrize.
Pediatrics Journal publishes results of child trial of Cold-fX
08/05/2008
Pediatrics - the official journal of the American Academy of Pediatrics and a prestigious medical journal - has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®.
TEC VenturePrize awards Alberta's best entrepreneurs
30/04/2008
With over $150,000 in cash and business development services on the line, Datagardens, the winner of the Fast Growth Award walked away with an awards package valued at $90,000 and the two runners up Simple Solar and Tagle received over $38,000 in prizes.
TEC Center's grand opening
11/04/2008
With over 90% of the tenant space occupied, TEC Edmonton officially opened the doors of the TEC Centre, a lab and incubation facility for entrepreneurs, spin-off and start-up technology companies, located on the fourth floor of Enterprise Square.
Athena Environmental Sciences, Inc. signs agreement
24/01/2008
Athena Environmental Sciences, Inc. announced today that it has signed two licensing agreements with TEC Edmonton, on behalf of The Governors of the University of Alberta, for their patented protein expression technologies.
BioMS links with pharmaceutical giant
9/01/2008
BioMS Medical Corp. has signed one of the biggest drug licensing and development deals ever in Canada for its multiple sclerosis treatment.
New TEC Source provides expert business advice
04/09/2007
TEC Edmonton today announced the launch of a new program that helps create and grow technology enterprises in the Edmonton region by providing expert business development advice to start-up companies, free of charge.
Student receives scholarship for Energy Research Excellence
30/08/2007
The University of Alberta PhD student is one of the inaugural recipients of the Len Bolger Memorial Scholarship for Energy Research Excellence.
Microchip company to develop microfluidic devices
23/08/2007
Microchip Biotechnologies, Inc. (MBI) and TEC Edmonton have entered into an exclusive patent license agreement that allows MBI to commercialize a University of Alberta invention that can improve the development of lab-on-a-chip devices and biosampling procedures.
Task force delivers report on technology commercialization in Alberta
14/08/2007
A Value-Added and Technology Commercialization Report recently delivered to Advanced Education and Technology Minister Doug Horner will help the government determine immediate and long-term actions to enhance Alberta's ability to create, grow and sustain globally competitive and innovative knowledge intensive companies.
Micralyne and U of A win kudos for thin film innovation
09/08/2007
Micralyne Inc., a world leading independent MEMS (Micro-Electro-Mechanical-Systems) microfabrication company, and its GLAD (GLancing Angle Deposition) technology, developed in collaboration with Dr. Michael Brett at the University of Alberta, has been selected by R&D Magazine as one of the top 25 MICRO/NANO innovative products for 2007.
Synodon completes successful test of realSens
25/07/2007
Edmonton-based Synodon Inc. (”Synodon”) [TSXV-SYD], announced today that is has successfully completed the first phase of laboratory testing with its recently built field-deployable realSensTM instrument.
Scanimetrics unveils first product
16/07/2007
(San Fransico, California) Scanimetrics, Inc., a start-up company that helps enable Moore’s Law for nanoscale devices, officially debuted today with the launch of its first product in the semiconductor test market, a revolutionary non-contact, “virtual probe” testing technology for the semiconductor industry.
Biomira appoints industry veteran as Chief Operating Officer
17/07/2007
Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) today announced the appointment of Gary Christianson to the newly created position of Chief Operating Officer. Mr. Christianson brings to Biomira more than 20 years of operational expertise in diverse areas, including technical development, manufacturing of pharmaceutical products, facilities design and management, and personnel development.
CardioMetabolics Inc. gains approval for Phase II Trial
11/07/2007
CardioMetabolics Inc., a Canadian biopharmaceutical company, announced today that all approvals have been received authorizing the start of their Phase II “Mini-METRxICS” Clinical Trial, which is aimed at reducing Intensive Care Unit (ICU) stays in geriatric patients undergoing cardiopulmonary bypass surgery.
New vice-president focused on making a difference
03/07/2007
(Edmonton, Alberta) The power of research lies in the ability to improve people's quality of life, according to the University of Alberta's new vice-president of research.
CadioMetabolics secures $4 M in funding
31/05/2007
CardioMetabolics Inc., a Canadian biopharmaceutical company, announced today that it has secured over $4 million in private equity financing to advance work on drug candidates being developed for the treatment of cardiovascular disease and related metabolic conditions, such as diabetes.
Discovery licensed to neuroscience firm Cortex
10/05/2007
Patent license agreement could broaden the use of AMPAKINE® compounds to prevent opiate- and barbiturate-induced respiratory depression IRVINE, CA and Edmonton, AB -- The Board of Directors of Cortex Pharmaceuticals, Inc. (AMEX:COR) and TEC Edmonton on behalf of The Governors of the University of Alberta jointly announced that they have entered into an exclusive Patent License Agreement that could broaden the use of Cortex’s AMPAKINE® technology to prevent and treat opiate- and barbiturate-induced respiratory depression.
Female ticks have the market on gluttony
03/05/2007
Sex makes you fat. If you're a female tick, that is.
Top Alberta student business plans
26/04/2007
VenturePrize today announced the five university students vying for $10,000 in cash prizes awarded in the Alberta Student Business Plan Competition on May 3 at the Annual Awards Luncheon at the Shaw Conference Centre.
Semi-finalists announced for VenturePrize
26/03/2007
A firm that developed specialized software for veterinary hospitals, an innovative IT utility service provider, and a company with a device that analyses breath gas to diagnose certain ailments have been named the 2006-07 finalists in VenturePrize, the Alberta Business Plan Competition.
Task force targets actions with ling-term impact
27/03/2007
Task force targets actions with long-term impact on Alberta's diversity and continued prosperity
TEC VenturePrize awards luncheon
21/03/2007
TEC Edmonton officially opened ticket sales to the 2007 VenturePrize Business Plan Competition Awards Luncheon, scheduled for May 3, 2007, at Edmonton’s Shaw Conference Centre.
AHFMR gives TEC Edmonton funding
21/02/2007
TEC Edmonton and the Alberta Heritage Foundation for Medical Research (AHFMR) are pleased to announce new funding to help move Edmonton inventions closer to the marketplace.
WD invests $15 million to establish TEC Centre
19/12/2006
High-tech companies and entrepreneurs got a boost today with a $15-million federal investment to establish the TEC Centre at the University of Alberta’s Enterprise Square.
TRLabs receives $22.3M in support
18/12/2006
The governments of Canada and Alberta announced a $22.3 million re-investment over five years in TRLabs, a consortium spinoff launched by the University of Alberta in 1986. The investment includes $10 million from the federal government, $2.4 million each from the Governments of Manitoba and Saskatchewan, and $7.5 million from the Government of Alberta.
TEC Edmonton deploys multiple programs
13/12/2006
How do you develop, educate and retain entrepreneurs in Alberta? A new province-wide initiative is about to provide a solution. Two organizations that have independently delivered programs and expertise to foster entrepreneurial talent are pooling efforts to launch Ingenuity Enterprise.
Leading GPS firm aquires U of A spin-off Dynastream
01/12/2006
Garmin Ltd. (Nasdaq: GRMN) announced today that it acquired Dynastream Innovations Inc. for approximately $36 million in cash. Dynastream will continue operations as a wholly-owned subsidiary of Garmin Ltd.
BioMS begins remitting multiple sclerosis trial
24/11/2006
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), announced yesterday that the first patients have been enrolled in its placebo controlled multi-center Phase II clinical trial of MBP8298 for the treatment of relapsing remitting multiple sclerosis (RRMS).
TheraCarb named "Best Company" at national financial forum
23/11/2006
TheraCarb was awarded the Forum Favorite Award for Best Company – Biotechnology, at the Canadian Financing Forum held on November 13th and 14th in Vancouver.
COLD-fX clinical trial results added to major publication
01/11/2006
CV Technologies Inc., maker of COLD-fX®, today provided an update to the business, scientific and investment community. The University of Alberta spinoff company has gained significant exposure from several publications.
Biomira Announces Acquisition of ProlX Pharmaceuticals
31/10/2006
Biomira Inc. announced today that it has acquired ProlX Pharmaceuticals Corporation, of Tucson, Arizona, and Houston, Texas, a privately-held biopharmaceutical company focused on the development of novel therapeutics for the treatment of cancer. ProlX is developing small-molecule drugs that inhibit redox and cell-survival signaling proteins.
TEC Edmonton names 1st Board of Directors
30/10/2006
TEC Edmonton today announced the members of its first Board of Directors, comprised of experienced leaders mainly from the private-sector.
Cardiometabolics announces new CEO
30/10/2006
Dr. Larry Ohlhauser, Board Chair of CardioMetabolics Inc. announced today the appointment of Mr. Kimmo Lucas, MBA, as President and CEO of the University of Alberta spin-off company.
Grad Student wins NSERC Award for entrepreneurialism
26/10/2006
Yunfei Chen, a Ph.D. trainee under iCORE Chair, Professor Norman C. Beaulieu, has won an Honourable Mention in the NSERC Innovation Challenge Award competition for his work "Novel Technologies for Advanced Wireless Communication." NSERC’s Synergy and Innovation Awards Gala was held October 16, 2006 in Winnipeg, Manitoba.
EEDC boss presented with TEC Edmonton Enterprise Award
19/20/2006
Dr. Gary Kachanoski, Vice-President of Research for the University of Alberta, and Chairman of the TEC Edmonton Board of Directors joined Mayor Mandel in presenting the inaugural TEC Edmonton Enterprise Award to Allan Scott, President and CEO of Edmonton Economic Development Corporation, a post he is leaving in March 2007.
BioAlberta and TEC Edmonton forge alliance
18/10/2006
EC Edmonton signed a Memorandum of Understanding with the Alberta Biotechnology Association, commonly known as BioAlberta, to create opportunities where the two organizations can cooperate to strengthen companies in the Edmonton capital region.
New role created to grow tech startups
17/10/2006
TEC Edmonton today announced the creation of the position of Vice-President of Company Development and promoted the former manager of the JumpStart Program to the new position.
Precarn to provide $2 million to small companies
17/10/2006
Ottawa-based Precarn Incorporated has announced that it will provide a $2 million funding boost to support the intelligent systems (IS) and robotics research and development (R&D) efforts of small businesses across Canada.
Cevena Bioproducts appoint Rod Charko as CEO
16/10/2006
The Board of Directors of Cevena Bioproducts has announced that Rod Charko has been appointed President and CEO of the company.
Scanimetrics announces $6.5 million financing
4/10/2006
Scanimetrics Inc., an Edmonton-based semiconductor testing company, recently completed the second tranche in a total equity financing in excess of $6.5 million.
VenturePrize adds student category
3/10/2006
The 2006-07 VenturePrize Business Plan Competition will offer a new category exclusively for Alberta university and college students who want to turn high-growth ideas into business ventures.
CardioMetabolics issues third patent
3/08/2006
CardioMetabolics Inc. (CMI) announced today that it has been issued patent #US 7,074,828 B2 titled “Compounds That Stimulate Glucose Utilization and Methods of Use” from the U.S. Patent Office (USPTO) for novel compositions, formulations, methods, and use of compounds – drug compounds for the treatment including conditions arising from cardiovascular (CVD) and diabetic diseases.
TEC VenturePrize participant to participate in Dragons Den
31/07/2006
A semifinalist in TEC Edmonton's 2005-06 VenturePrize competion has become a contender in a prime-time TV battle with a chance to secure up to $1 million from high-profile investors.
U of A keen on cutting edge technology
10/07/2006
Edmonton -- Forget the phrase, "sharp as a tack." Now, thanks to new University of Alberta research the popular expression might become, "sharp as a single atom tip formed by chemically assisted spatially controlled field evaporation."
Tribute to Dr. Tony Noujaim
07/07/2006
With deep sadness we join many Edmontonians in expressing our sorrow for the loss of one of Alberta’s true champions: Dr. Tony Noujaim.
IBM donates $1.2 Million to super computer
04/07/2006
A high-capability, $1.2-million supercomputer donated by IBM will help University of Alberta researchers ask - and answer - more big questions.
BioMS receives regulatory approval for trial
16/05/2006
EDMONTON, Alberta - BioMS Medical Corp (TSX: MS), a leading developer of products for the treatment of multiple sclerosis (MS), announced that it has received regulatory approval to initiate a phase II human clinical trial to investigate the efficacy and safety of MBP8298 in patients with relapsing-remitting multiple sclerosis (RRMS) in the first of several European countries.
Cold-fX maker CV Technologies sets up U.S. firm
09/05/2006
Edmonton-based CV Technologies Inc. (TSX:CVQ), maker of COLD-fX™, today announced that a wholly owned subsidiary, COLD-fX Pharmaceuticals (USA) Inc., has been established to facilitate international expansion into the United States.
New software is next wave for net surfers
25/04/2006
With an estimated 12 billion websites online, it's not always easy finding the exact site you want. However, University of Alberta computer scientists have developed software they believe will make surfing the Web faster and easier.
Podcasters win business prize
20/04/2006
A couple of University of Alberta students are starting to hear the sweet sounds of success.
Alberta Science & Tech Foundation opens nominations
01/04/2006
ASTech announced its call for nominations for this year's ASTech Awards, which recognize outstanding contributions and major achievements in science and technology. This year, there are six awards and five prizes.
U of A health researchers receive $24.5 million from AHFMR
23/03/2006
Dr. Jason Dyck is one of 34 University of Alberta health researchers receiving new funding from the Alberta Heritage Foundation for Medical Research.
Funding for genome research
22/03/2006
Researchers at the University of Alberta today celebrated the creation of a new research funding body, Genome Alberta, and $4.3 million in provincial funding for genomics research in Alberta.
Greeting card maker wins 1st KickStart Award
8/03/2006
After a tense showdown where four new entrepreneurs presented their business plans to an audience of business professionals at the Alberta Research Council auditorium on March 7, a company that makes novel greeting cards that can be turned into candles was crowned the inaugural KickStart champion in this new category of the annual VenturePrize, the Alberta-wide Business Plan Competition.
Gadget helps people with spinal cord injuries regain mobility
6/03/2006
The last thing Edgar Jackson saw before he hit the ground was a bent traffic sign that had been thrown into the air by the force of his motorcycle.
VenturePrize names KickStart finalists
01/03/2006
VenturePrize, Alberta’s Business Plan Competition, today announced the selection of the four Alberta entrepreneurs who will be vying for over $19,000 in prizes in the Entrepreneurial KickStart award category, a new competition launched this year for newer and smaller business ideas than the companies competing in the $156,000 Fast-Growth category.
CV Technologies unveils Cold-fX plans for U.S.
27/02/2006
CV Technologies Inc. today announces its plans for entry into the United States. Company President, CEO and Chief Scientific Officer Dr. Jacqueline Shan will unveil the Company’s future U.S. growth strategy at its annual general meeting in Edmonton this afternoon.
Executive-in-Residence recruited to help grow biotech firms
22/02/2006
TEC Edmonton and the Alberta Heritage Foundation for Medical Research (AHFMR) today announced the recruitment of an Executive-in-Residence who will help improve the viability and growth potential of several new University of Alberta spinoff companies.
BioMS expands and accelerates pivotal trial
17/02/2006
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced fourth quarter and year-end results for the year ended December 31, 2005.
VenturePrize announces semifinalists
15/02/2006
VenturePrize, Alberta’s Business Plan Competition, today announced the selection of the six Alberta entrepreneurs – from Edmonton and Calgary – who will be vying for over $156,000 in prizes in the Fast-Growth award category.
Biomira completes U.S. $16.07 million financing
08/02/2006
EDMONTON, Alberta - Biomira Inc. (Nasdaq: BIOM) (TSX: BRA) today announced the completion at the end of January of its financing totaling U.S. $16,070,000, with Rodman & Renshaw LLC of New York acting as exclusive placement agent.
U of A inventor helps improve wireless communications
07/02/2006
UTEK Corporation (AMEX:UTK; LSE-AIM:UTKA), a technology transfer company, and WebSky, Inc. (Pink Sheets: WKYN ), a developer and operator of wireless broadband services over licensed frequencies in underserved foreign and domestic markets, announced today that WebSky, Inc. has acquired Strategic Wireless Solutions, Inc., a subsidiary of UTEK Corporation, in a stock transaction.
TEC Edmonton announces new CEO
31/01/2006
Dr. Gary Kachanoski, incoming Chair of the Board of Directors of TEC Edmonton, announced today the appointment of Dr. David J. Cox as CEO of TEC Edmonton, effective 1 April 2006.
BioMS Medical retains ICON for pivotal MS trial
26/01/2006
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that it has signed a letter of intent establishing ICON (ICON; NASDAQ: ICLR) as the global clinical research organization (CRO) for the Company's ongoing pivotal phase II/III clinical trial for MBP8298 for the treatment of multiple sclerosis.
Cattle byproduct may help in fire fighting
25/01/2006
What have cattle got to do with firefighters or oil wells? Quite a bit, as it turns out. Cattle produce meat and milk for our tables, and now the University of Alberta is discovering new ways to use a cattle byproduct that was devalued in the wake of mad cow disease (BSE).
Spinoff company TheraCarb partners with healthcare firm
23/01/2006
(AITHERSBURG, Md.) BioVeris Corporation (Nasdaq: BIOV - News) announced today that it has entered into an option agreement with TheraCarb, Inc. of Edmonton, Alberta, for exclusive patent rights to a vaccine candidate for Candida albicans, the most common fungal pathogen affecting humans.
TEC Edmonton's Annual Report shows record year
16/01/2006
TEC Edmonton's Annual Report, published Jan. 11, announced the results of technology commercialization activities for the 2004-05 fiscal period – the first complete year for the new joint venture organization.
Cevena Bioproducts Adds Top Marketing Talent to Team
12/01/2006
Cevena Bioproducts announced today the appointment of Nina Likins as marketing director. Likins, who has a stellar track record of moving a novel branded ingredient into the mainstream through innovative brand-building techniques, will bring her marketing acumen to accomplish mainstream recognition of Viscofiber®, the flagship ingredient from Cevena.
BioMS Medical increases equity position
6/01/2006
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that it has exercised its option to purchase additional equity in BioCyDex Inc., a private company based in Edmonton, bringing BioMS Medical's total equity position to 49%.